A citation-based method for searching scientific literature

I Arijs, K Li, G Toedter, R Quintens, L Van Lommel, K Van Steen, P Leemans, G De Hertogh, K Lemaire, M Ferrante, F Schnitzler, L Thorrez, K Ma, X-Y R Song, C Marano, G Van Assche, S Vermeire, K Geboes, F Schuit, F Baribaud, P Rutgeerts. Gut 2009
Times Cited: 236







List of co-cited articles
911 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease.
Nathaniel R West, Ahmed N Hegazy, Benjamin M J Owens, Samuel J Bullers, Bryan Linggi, Sofia Buonocore, Margherita Coccia, Dieter Görtz, Sébastien This, Krista Stockenhuber,[...]. Nat Med 2017
265
41

Predictive value of epithelial gene expression profiles for response to infliximab in Crohn's disease.
Ingrid Arijs, Roel Quintens, Leentje Van Lommel, Kristel Van Steen, Gert De Hertogh, Katleen Lemaire, Anica Schraenen, Clémentine Perrier, Gert Van Assche, Séverine Vermeire,[...]. Inflamm Bowel Dis 2010
111
32

Cell-centred meta-analysis reveals baseline predictors of anti-TNFα non-response in biopsy and blood of patients with IBD.
Renaud Gaujoux, Elina Starosvetsky, Naama Maimon, Francesco Vallania, Haggai Bar-Yoseph, Sigal Pressman, Roni Weisshof, Idan Goren, Keren Rabinowitz, Matti Waterman,[...]. Gut 2019
75
36

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.
Luke Jostins, Stephan Ripke, Rinse K Weersma, Richard H Duerr, Dermot P McGovern, Ken Y Hui, James C Lee, L Philip Schumm, Yashoda Sharma, Carl A Anderson,[...]. Nature 2012
23

In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease.
Raja Atreya, Helmut Neumann, Clemens Neufert, Maximilian J Waldner, Ulrike Billmeier, Yurdagül Zopf, Marcus Willma, Christine App, Tino Münster, Hermann Kessler,[...]. Nat Med 2014
228
19

Infliximab for induction and maintenance therapy for ulcerative colitis.
Paul Rutgeerts, William J Sandborn, Brian G Feagan, Walter Reinisch, Allan Olson, Jewel Johanns, Suzanne Travers, Daniel Rachmilewitz, Stephen B Hanauer, Gary R Lichtenstein,[...]. N Engl J Med 2005
18

Vedolizumab as induction and maintenance therapy for ulcerative colitis.
Brian G Feagan, Paul Rutgeerts, Bruce E Sands, Stephen Hanauer, Jean-Frédéric Colombel, William J Sandborn, Gert Van Assche, Jeffrey Axler, Hyo-Jong Kim, Silvio Danese,[...]. N Engl J Med 2013
18

Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel disease.
Bram Verstockt, Sare Verstockt, Jonas Dehairs, Vera Ballet, Helene Blevi, Willem-Jan Wollants, Christine Breynaert, Gert Van Assche, Séverine Vermeire, Marc Ferrante. EBioMedicine 2019
46
39

Association Between Response to Etrolizumab and Expression of Integrin αE and Granzyme A in Colon Biopsies of Patients With Ulcerative Colitis.
Gaik W Tew, Jason A Hackney, Deena Gibbons, Christopher A Lamb, Diana Luca, Jackson G Egen, Lauri Diehl, Jeff Eastham Anderson, Severine Vermeire, John C Mansfield,[...]. Gastroenterology 2016
88
19

Gene expression profiling and response signatures associated with differential responses to infliximab treatment in ulcerative colitis.
Gary Toedter, Katherine Li, Colleen Marano, Keying Ma, Sarah Sague, C Chris Huang, Xiao-Yu Song, Paul Rutgeerts, Frédéric Baribaud. Am J Gastroenterol 2011
57
29

Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases.
Ashwin N Ananthakrishnan, Chengwei Luo, Vijay Yajnik, Hamed Khalili, John J Garber, Betsy W Stevens, Thomas Cleland, Ramnik J Xavier. Cell Host Microbe 2017
143
17

Gene expression profiling of CD8+ T cells predicts prognosis in patients with Crohn disease and ulcerative colitis.
James C Lee, Paul A Lyons, Eoin F McKinney, John M Sowerby, Edward J Carr, Francesca Bredin, Hannah M Rickman, Huzefa Ratlamwala, Alexander Hatton, Tim F Rayner,[...]. J Clin Invest 2011
181
16

Mucosal gene expression of antimicrobial peptides in inflammatory bowel disease before and after first infliximab treatment.
Ingrid Arijs, Gert De Hertogh, Katleen Lemaire, Roel Quintens, Leentje Van Lommel, Kristel Van Steen, Peter Leemans, Isabelle Cleynen, Gert Van Assche, Séverine Vermeire,[...]. PLoS One 2009
133
16

Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study.
Subra Kugathasan, Lee A Denson, Thomas D Walters, Mi-Ok Kim, Urko M Marigorta, Melanie Schirmer, Kajari Mondal, Chunyan Liu, Anne Griffiths, Joshua D Noe,[...]. Lancet 2017
267
16

Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations.
Jimmy Z Liu, Suzanne van Sommeren, Hailiang Huang, Siew C Ng, Rudi Alberts, Atsushi Takahashi, Stephan Ripke, James C Lee, Luke Jostins, Tejas Shah,[...]. Nat Genet 2015
985
15

Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.
Brian G Feagan, William J Sandborn, Christopher Gasink, Douglas Jacobstein, Yinghua Lang, Joshua R Friedman, Marion A Blank, Jewel Johanns, Long-Long Gao, Ye Miao,[...]. N Engl J Med 2016
700
15

Effect of vedolizumab (anti-α4β7-integrin) therapy on histological healing and mucosal gene expression in patients with UC.
Ingrid Arijs, Gert De Hertogh, Bart Lemmens, Leentje Van Lommel, Magali de Bruyn, Wiebe Vanhove, Isabelle Cleynen, Kathleen Machiels, Marc Ferrante, Frans Schuit,[...]. Gut 2018
72
20

Associations between functional polymorphisms in the NFκB signaling pathway and response to anti-TNF treatment in Danish patients with inflammatory bowel disease.
S Bank, P S Andersen, J Burisch, N Pedersen, S Roug, J Galsgaard, S Y Turino, J B Brodersen, S Rashid, B K Rasmussen,[...]. Pharmacogenomics J 2014
80
17

Ulcerative colitis mucosal transcriptomes reveal mitochondriopathy and personalized mechanisms underlying disease severity and treatment response.
Yael Haberman, Rebekah Karns, Phillip J Dexheimer, Melanie Schirmer, Judith Somekh, Ingrid Jurickova, Tzipi Braun, Elizabeth Novak, Laura Bauman, Margaret H Collins,[...]. Nat Commun 2019
78
17

Disease activity, ANCA, and IL23R genotype status determine early response to infliximab in patients with ulcerative colitis.
Matthias Jürgens, Rüdiger P Laubender, Franziska Hartl, Maria Weidinger, Julia Seiderer, Johanna Wagner, Martin Wetzke, Florian Beigel, Simone Pfennig, Johannes Stallhofer,[...]. Am J Gastroenterol 2010
116
13

Polymorphisms in apoptosis genes predict response to infliximab therapy in luminal and fistulizing Crohn's disease.
T Hlavaty, M Pierik, L Henckaerts, M Ferrante, S Joossens, N van Schuerbeek, M Noman, P Rutgeerts, S Vermeire. Aliment Pharmacol Ther 2005
127
13

Systematic review: genetic biomarkers associated with anti-TNF treatment response in inflammatory bowel diseases.
S Bek, J V Nielsen, A B Bojesen, A Franke, S Bank, U Vogel, V Andersen. Aliment Pharmacol Ther 2016
49
26

Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature.
Yael Haberman, Timothy L Tickle, Phillip J Dexheimer, Mi-Ok Kim, Dora Tang, Rebekah Karns, Robert N Baldassano, Joshua D Noe, Joel Rosh, James Markowitz,[...]. J Clin Invest 2014
281
13

Single-Cell Analysis of Crohn's Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy.
Jerome C Martin, Christie Chang, Gilles Boschetti, Ryan Ungaro, Mamta Giri, John A Grout, Kyle Gettler, Ling-Shiang Chuang, Shikha Nayar, Alexander J Greenstein,[...]. Cell 2019
146
13

Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study.
Isabelle Cleynen, Gabrielle Boucher, Luke Jostins, L Philip Schumm, Sebastian Zeissig, Tariq Ahmad, Vibeke Andersen, Jane M Andrews, Vito Annese, Stephan Brand,[...]. Lancet 2016
359
12

Vedolizumab as induction and maintenance therapy for Crohn's disease.
William J Sandborn, Brian G Feagan, Paul Rutgeerts, Stephen Hanauer, Jean-Frédéric Colombel, Bruce E Sands, Milan Lukas, Richard N Fedorak, Scott Lee, Brian Bressler,[...]. N Engl J Med 2013
12

Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial.
Séverine Vermeire, Sharon O'Byrne, Mary Keir, Marna Williams, Timothy T Lu, John C Mansfield, Christopher A Lamb, Brian G Feagan, Julian Panes, Azucena Salas,[...]. Lancet 2014
282
12

Genome wide association (GWA) predictors of anti-TNFalpha therapeutic responsiveness in pediatric inflammatory bowel disease.
Marla C Dubinsky, Ling Mei, Madison Friedman, Tanvi Dhere, Talin Haritunians, Hakon Hakonarson, Cecilia Kim, Joseph Glessner, Stephan R Targan, Dermot P McGovern,[...]. Inflamm Bowel Dis 2010
95
12

Genetic Markers Predict Primary Non-Response and Durable Response To Anti-TNF Biologic Therapies in Crohn's Disease.
Grant E Barber, Vijay Yajnik, Hamed Khalili, Cosmas Giallourakis, John Garber, Ramnik Xavier, Ashwin N Ananthakrishnan. Am J Gastroenterol 2016
44
27

Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn's Disease: A Phase 2a Study.
Bruce E Sands, Jingjing Chen, Brian G Feagan, Mark Penney, William A Rees, Silvio Danese, Peter D R Higgins, Paul Newbold, Raffaella Faggioni, Kaushik Patra,[...]. Gastroenterology 2017
129
12

Ulcerative colitis.
Ryan Ungaro, Saurabh Mehandru, Patrick B Allen, Laurent Peyrin-Biroulet, Jean-Frédéric Colombel. Lancet 2017
826
12

Mucosal IL13RA2 expression predicts nonresponse to anti-TNF therapy in Crohn's disease.
Bram Verstockt, Sare Verstockt, Brecht Creyns, Sophie Tops, Gert Van Assche, Ann Gils, Jan L Ceuppens, Séverine Vermeire, Marc Ferrante, Christine Breynaert. Aliment Pharmacol Ther 2019
26
46

Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis.
Christopher S Smillie, Moshe Biton, Jose Ordovas-Montanes, Keri M Sullivan, Grace Burgin, Daniel B Graham, Rebecca H Herbst, Noga Rogel, Michal Slyper, Julia Waldman,[...]. Cell 2019
215
12

NOD2/CARD15 does not influence response to infliximab in Crohn's disease.
Severine Vermeire, Edouard Louis, Paul Rutgeerts, Martine De Vos, Andre Van Gossum, Jacques Belaiche, Paul Pescatore, Rene Fiasse, Paul Pelckmans, Robert Vlietinck,[...]. Gastroenterology 2002
173
11

Gene Expression Signature for Prediction of Golimumab Response in a Phase 2a Open-Label Trial of Patients With Ulcerative Colitis.
Shannon E Telesco, Carrie Brodmerkel, Hongyan Zhang, Lilianne Lee-Lian Kim, Jewel Johanns, Abhijit Mazumder, Katherine Li, Frédéric Baribaud, Mark Curran, Richard Strauss,[...]. Gastroenterology 2018
25
44

Expansion of IL-23 receptor bearing TNFR2+ T cells is associated with molecular resistance to anti-TNF therapy in Crohn's disease.
Heike Schmitt, Ulrike Billmeier, Walburga Dieterich, Timo Rath, Sophia Sonnewald, Stephen Reid, Simon Hirschmann, Kai Hildner, Maximilian J Waldner, Jonas Mudter,[...]. Gut 2019
53
20

Crohn's disease.
Joana Torres, Saurabh Mehandru, Jean-Frédéric Colombel, Laurent Peyrin-Biroulet. Lancet 2017
596
11

TREM-1, the ideal predictive biomarker for endoscopic healing in anti-TNF-treated Crohn's disease patients?
Bram Verstockt, Sare Verstockt, Helene Blevi, Isabelle Cleynen, Magali de Bruyn, Gert Van Assche, Séverine Vermeire, Marc Ferrante. Gut 2019
23
47

A multicenter experience with infliximab for ulcerative colitis: outcomes and predictors of response, optimization, colectomy, and hospitalization.
Abderrahim Oussalah, Ludovic Evesque, David Laharie, Xavier Roblin, Gilles Boschetti, Stéphane Nancey, Jérôme Filippi, Bernard Flourié, Xavier Hebuterne, Marc-André Bigard,[...]. Am J Gastroenterol 2010
128
10

Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.
William J Sandborn, Chinyu Su, Bruce E Sands, Geert R D'Haens, Séverine Vermeire, Stefan Schreiber, Silvio Danese, Brian G Feagan, Walter Reinisch, Wojciech Niezychowski,[...]. N Engl J Med 2017
537
10

Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's disease.
E Louis, Z El Ghoul, S Vermeire, S Dall'Ozzo, P Rutgeerts, G Paintaud, J Belaiche, M De Vos, A Van Gossum, J-F Colombel,[...]. Aliment Pharmacol Ther 2004
158
10

Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn's disease.
Severine Vermeire, Edouard Louis, An Carbonez, Gert Van Assche, Maja Noman, Jacques Belaiche, Martine De Vos, Andre Van Gossum, Paul Pescatore, Rene Fiasse,[...]. Am J Gastroenterol 2002
174
10

Anti-TNF Therapy Response in Patients with Ulcerative Colitis Is Associated with Colonic Antimicrobial Peptide Expression and Microbiota Composition.
Maria K Magnusson, Hans Strid, Maria Sapnara, Anders Lasson, Antal Bajor, Kjell-Arne Ung, Lena Öhman. J Crohns Colitis 2016
72
13

Cytokines in inflammatory bowel disease.
Markus F Neurath. Nat Rev Immunol 2014
10

Predictive model for the outcome of infliximab therapy in Crohn's disease based on apoptotic pharmacogenetic index and clinical predictors.
Tibor Hlavaty, Marc Ferrante, Liesbet Henckaerts, Marie Pierik, Paul Rutgeerts, Severine Vermeire. Inflamm Bowel Dis 2007
50
18


Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study.
Brian G Feagan, William J Sandborn, Geert D'Haens, Julián Panés, Arthur Kaser, Marc Ferrante, Edouard Louis, Denis Franchimont, Olivier Dewit, Ursula Seidler,[...]. Lancet 2017
224
9

Mucosal cytokine gene expression profiles as biomarkers of response to infliximab in ulcerative colitis.
Renathe Rismo, Trine Olsen, Guanglin Cui, Ingrid Christiansen, Jon Florholmen, Rasmus Goll. Scand J Gastroenterol 2012
49
18

Fecal Microbiota in Pediatric Inflammatory Bowel Disease and Its Relation to Inflammation.
Kaija-Leena Kolho, Katri Korpela, Tytti Jaakkola, Madharasi V A Pichai, Erwin G Zoetendal, Anne Salonen, Willem M de Vos. Am J Gastroenterol 2015
116
9

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial.
Jean-Frédéric Colombel, William J Sandborn, Paul Rutgeerts, Robert Enns, Stephen B Hanauer, Remo Panaccione, Stefan Schreiber, Dan Byczkowski, Ju Li, Jeffrey D Kent,[...]. Gastroenterology 2007
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.